All Stories

  1. Feeding the estrobolome with sweet prebiotics?
  2. RECALCITRANT CANCERS: WHERE ARE WE NOW?
  3. Liquid biopsy in breast cancer: current biomarker platforms and clinical applications
  4. Editorial: Epigenetic modulation in cancer
  5. The AGE–RAGE Pathway in Endometriosis: A Focused Mechanistic Review and Structured Evidence Map
  6. Darunavir analog precursors target mitochondrial metabolism in multiple myeloma and CLL.
  7. Cachexia, Sarcopenia, Malnutrition and Their Impact on Survival in Cervical Cancer Patients.
  8. A CRITICAL ANALYSIS OF THE ROLE OF FASTING IN CLINICAL ONCOLOGY AND AGEING: DISPELLING A MYTH
  9. Molecular Mechanisms and Clinical Divergences in HPV-Positive Cervical vs. Oropharyngeal Cancers: A Critical Narrative Review
  10. Laparoscopic treatment of a rare primary peritoneal serous borderline tumor.
  11. Correction: Liquid biopsy in gynecological cancers: a translational framework from molecular insights to precision oncology and clinical practice
  12. Liquid biopsy in gynecological cancers: from molecular insights to precision oncology.
  13. Vitamins and dietary supplements in cancer treatment: is there a need for increased usage?
  14. Laparoscopic Treatment of a Rare Primary Peritoneal Serous Borderline Tumor: Case Report and Narrative Review of the Literature
  15. Cancer knocks you out by fasting: Cachexia as a consequence of metabolic alterations in cancer
  16. Multiple aspects of matrix stiffness in cancer progression
  17. Can the benefits of Calorie Restriction and Periodic Fasting be transferred from mice to humans?
  18. Role of Nutrition, Inflammation and Epigenetic in Cancer
  19. Lipid Handling Induces Ferroptosis and Conveys Sensitivity to Anti-BCMA Immunotherapy in Multiple Myeloma
  20. 1068P Fasting mimicking diet reduces anti-OX40/anti PD-L1 and anti-PD-1/anti-CTLA-4 cardiovascular side effects in melanoma and lung cancer models
  21. Fasting mimicking diet in mice delays cancer growth and reduces immunotherapy-associated cardiovascular and systemic side effects
  22. Metabolites and Immune Response in Tumor Microenvironments
  23. Fasting renders immunotherapy effective against low-immunogenic breast cancer while reducing side effects
  24. Fasting-Mimicking Diet Is Safe and Reshapes Metabolism and Antitumor Immunity in Patients with Cancer
  25. Author Correction: Fasting-mimicking diet and hormone therapy induce breast cancer regression
  26. Fasting, dietary restriction, and immunosenescence
  27. Fasting-mimicking diet and hormone therapy induce breast cancer regression
  28. Modification of the base excision repair enzyme MBD4 by the small ubiquitin-like molecule SUMO1
  29. Reply to ‘Fasting in oncology: a word of caution’
  30. Fasting and cancer: molecular mechanisms and clinical application
  31. Thymine DNA Glycosylase (TDG) is involved in the pathogenesis of intestinal tumors with reduced APC expression
  32. Enhancing Stem Cell Transplantation with “Nutri-technology”
  33. Involvement ofMBD4inactivation in mismatch repair-deficient tumorigenesis
  34. A RAB5/RAB4 recycling circuitry induces a proteolytic invasive program and promotes tumor dissemination
  35. CDC42 switches IRSp53 from inhibition of actin growth to elongation by clustering of VASP
  36. Thymine DNA Glycosylase Is Essential for Active DNA Demethylation by Linked Deamination-Base Excision Repair
  37. Defective ciliogenesis, embryonic lethality and severe impairment of the Sonic Hedgehog pathway caused by inactivation of the mouse complex A intraflagellar transport gene Ift122/Wdr10, partially overlapping with the DNA repair gene Med1/Mbd4
  38. The DNAN-Glycosylase MED1 Exhibits Preference for Halogenated Pyrimidines and Is Involved in the Cytotoxicity of 5-Iododeoxyuridine
  39. The base excision repair enzyme MED1 mediates DNA damage response to antitumor drugs and is associated with mismatch repair system integrity
  40. Dynamin Participates in Focal Extracellular Matrix Degradation by Invasive Cells
  41. Induction of Deoxyribonucleic Acid Damage by γ Irradiation
  42. Induction of Deoxyribonucleic Acid Damage by Alkylating Agents